L. Majoros

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Lászlo Majoros, Laszlo Majoros, L Majoros, László Majoros, László I. Majoros, László Majoros, Laszlo I. Majoros, L. Majoros, Laszlo I Majoros
Publication record
127 papers · 1,875 citations · H-index 23

PAPERS

ENA1 deficiency attenuates Saccharomyces 'boulardii' probiotic yeast virulence in immunosuppressed mouse fungaemia model.
20260 citationsauthor #9
Epidemiology and Clinical Relevance of Pneumocystis jirovecii in Non-Human Immunodeficiency Virus Patients at a Tertiary Care Center in Central Europe: A 3-Year Retrospective Study
20251 citationsauthor #4
Phylogenomic diversity of clinical Saccharomyces cerevisiae and the prevalence of probiotic-derived isolates in a tertiary care center in Hungary
20251 citationsauthor #4
First Report of Trichophyton indotineae Infection in Hungary
20257 citationsauthor #7
The in vitro activity of iron chelator deferiprone against Candida (Candidozyma) auris in combination with antifungal agents
20250 citationsauthor #3
A comprehensive analysis of the effect of quorum-sensing molecule 3-oxo-C12-homoserine lactone on Candida auris and Candida albicans
20254 citationsauthor #10
Epidemiology, clinical characteristics, outcome and biofilm forming properties in candidaemia: A single‐centre retrospective 4‐year analysis from Hungary
20245 citationsauthor #8
Bacteraemia Associated with Bilophila wadsworthia: A Rare Case Presentation from Hungary
20241 citationsauthor #10
In Vivo Efficacy of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in a Neutropenic Mouse Bloodstream Infection Model
20245 citationsauthor #11
Genomic epidemiology of antifungal resistance in human and avian isolates of Candida albicans: a pilot study from the One Health perspective
20243 citationsauthor #7
Isolate Specific Transcriptome Changes Exerted by Isavuconazole Treatment in Candida auris
20240 citationsauthor #6
Application of Biofire Filmarray Joint Infection Panel for Rapid Identification of Aetiology in a Necrotizing Fasciitis Case
20241 citationsauthor #5
Total transcriptome analysis of Candida auris planktonic cells exposed to tyrosol
20233 citationsauthor #11
Comparative transcriptional analysis of Candida auris biofilms following farnesol and tyrosol treatment
20238 citationsauthor #8
In Vitro Killing Activities of Anidulafungin and Micafungin with and without Nikkomycin Z against Four Candida auris Clades
20236 citationsauthor #10
Unveiling the Hungarian landscape of laboratory and clinical management capacities for invasive fungal infections: navigating the frontlines against fungal menaces
20237 citationsauthor #2
In Vivo Efficacy of Amphotericin B against Four Candida auris Clades
202210 citationsauthor #10
Physiological and transcriptional profiling of surfactin exerted antifungal effect against Candida albicans
20228 citationsauthor #11
Faecal Carriage of Carbapenem-Resistant Acinetobacter baumannii: Comparison to Clinical Isolates from the Same Period (2017–2019)
20229 citationsauthor #4
Heme Oxygenase-1 (HMX1) Loss of Function Increases the In-Host Fitness of the Saccharomyces ‘boulardii’ Probiotic Yeast in a Mouse Fungemia Model
20223 citationsauthor #4
The In Vitro Activity of Fluconazole, Amphotericin B and Echinocandins Against Cyberlindnera fabianii Planktonic Cells and Biofilms
20222 citationsauthor #8
Physiological and transcriptional profiling of surfactin exerted antifungal effect against Candida albicans.
202215 citationsauthor #12
Antifungal lock therapy: an eternal promise or an effective alternative therapeutic approach?
202214 citationsauthor #2
Synergistic Interaction of Caspofungin Combined with Posaconazole against FKS Wild-Type and Mutant Candida auris Planktonic Cells and Biofilms
202212 citationsauthor #9
Comparison of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Isolates From Rooks (Corvus frugilegus) and Contemporary Human-Derived Strains: A One Health Perspective
20228 citationsauthor #10
Comparison of In Vitro Killing Activity of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in RPMI-1640 in the Absence and Presence of Human Serum
202134 citationsauthor #8
Regulating primary microplastics in the European Union
20211 citationsauthor #6
Virulence Factors and in-Host Selection on Phenotypes in Infectious Probiotic Yeast Isolates (Saccharomyces ‘boulardii’)
20219 citationsauthor #12
Molecular Diversity and Genetic Relatedness of Candida albicans Isolates from Birds in Hungary
20218 citationsauthor #5
Unpredictable In Vitro Killing Activity of Amphotericin B against Four Candida auris Clades
20219 citationsauthor #10
Evolution of the Gram-Negative Antibiotic Resistance Spiral over Time: A Time-Series Analysis
20213 citationsauthor #6
The Role of Uniform Meropenem Usage in Acinetobacter baumannii Clone Replacement
20213 citationsauthor #9
Transcriptional Profiling of the Candida auris Response to Exogenous Farnesol Exposure
202123 citationsauthor #11
The Neosartorya fischeri Antifungal Protein 2 (NFAP2): A New Potential Weapon against Multidrug-Resistant Candida auris Biofilms
202127 citationsauthor #10
In vitro and in vivo interaction of caspofungin with isavuconazole against Candida auris planktonic cells and biofilms
202124 citationsauthor #7
Antifungal Activity of an Original Amino-Isocyanonaphthalene (ICAN) Compound Family: Promising Broad Spectrum Antifungals
20207 citationsauthor #7
Candida biofilm production is associated with higher mortality in patients with candidaemia
202057 citationsauthor #7
Fungal Quorum-Sensing Molecules: A Review of Their Antifungal Effect against Candida Biofilms
202060 citationsauthor #2
Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against Candida Species
202016 citationsauthor #10
In vitro and in vivo Effect of Exogenous Farnesol Exposure Against Candida auris
202046 citationsauthor #7
Comparison of in vivo pathogenicity of four Candida auris clades in a neutropenic bloodstream infection murine model
202083 citationsauthor #10
In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiae
201966 citationsauthor #9
Farnesol increases the activity of echinocandins against Candida auris biofilms.
201935 citationsauthor #6
Pharmacokinetic Properties of Fluorescently Labelled Hydroxypropyl-Beta-Cyclodextrin
201917 citationsauthor #6
Utilization of vector autoregressive and linear transfer models to follow up the antibiotic resistance spiral in Gram-negative bacteria from cephalosporin consumption to colistin resistance.
201916 citationsauthor #5
Physiological and Transcriptional Responses of Candida parapsilosis to Exogenous Tyrosol
201931 citationsauthor #9
Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms
201938 citationsauthor #6
Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida and Candida parapsilosis biofilms
20190 citationsauthor #6
Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis
20196 citationsauthor #9
Physiological and transcriptional response of Candida parapsilosis to exogenous tyrosol 1 2 Running headline : Effect of tyrosol in C . parapsilosis
20190 citationsauthor #10
In vitro antifungal susceptibility patterns of planktonic and sessile Candida kefyr clinical isolates
201818 citationsauthor #5
Comparison of Killing Activity of Micafungin Against Six Candida Species Isolated from Peritoneal and Pleural Cavities in RPMI-1640, 10 and 30% Serum
20185 citationsauthor #9
Fluconazole is not inferior than caspofungin, micafungin or amphotericin B in the presence of 50% human serum against Candida albicans and Candida parapsilosis biofilms.
20189 citationsauthor #6
Efficacy of antifungal agents in combination with farnesol against Candida albicans and Candida parapsilosis biofilms
20180 citationsauthor #1
In Vivo Applicability of Neosartorya fischeri Antifungal Protein 2 (NFAP2) in Treatment of Vulvovaginal Candidiasis
201831 citationsauthor #12
Poor in vivo efficacy of caspofungin, micafungin and amphotericin B against wild-type Candida krusei clinical isolates does not correlate with in vitro susceptibility results
20186 citationsauthor #8
Activity of exogenous tyrosol in combination with caspofungin and micafungin against Candida parapsilosis sessile cells
201717 citationsauthor #6
Killing Activity of Micafungin Against Candida albicans, C. dubliniensis and Candida africana in the Presence of Human Serum
20175 citationsauthor #9
Decreased Killing Activity of Micafungin Against Candida guilliermondii, Candida lusitaniae, and Candida kefyr in the Presence of Human Serum
20177 citationsauthor #7
Postantifungal effect of micafungin against Candida albicans, Candida dubliniensis and Candida africana in the presence and absence of serum.
20171 citationsauthor #8
Commercial strain-derived clinical Saccharomyces cerevisiae can evolve new phenotypes without higher pathogenicity.
20179 citationsauthor #11
Candida albicans isolates from a single hospital show low phenotypical specialization
20173 citationsauthor #5
Addressing Analytical Challenges of the Environmental Monitoring for the Water Framework Directive: ERM-CE100, a New Biota Certified Reference Material.
20177 citationsauthor #3
Comparison of the faecal colonization rates with extended-spectrum beta-lactamase producing enterobacteria among patients in different wards, outpatients and screened medical students
20162 citationsauthor #7
Killing Rates of Caspofungin in 50 Percent Serum Correlate with Caspofungin Efficacy Against Candida albicans in a Neutropenic Murine Model.
20165 citationsauthor #9
Asymptomatic faecal carriage of ESBL producing enterobacteriaceae in Hungarian healthy individuals and in long-term care applicants: A shift towards CTX-M producers in the community
201614 citationsauthor #5
Effects of hemin, CO2, and pH on the branching of Candida albicans filamentous forms.
20163 citationsauthor #7
Comparison of rates of fecal colonization with extended‐spectrum beta‐lactamase‐producing enterobacteria among patients in different wards, outpatients and medical students
201619 citationsauthor #6
Efficacy of caspofungin dose escalation against Candida albicans and Candida glabrata clinical isolates
20160 citationsauthor #1
The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model
20160 citationsauthor #3
Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms.
201648 citationsauthor #8
The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model
201633 citationsauthor #3
Dose escalation studies with caspofungin against Candida glabrata.
201514 citationsauthor #8
Betamethasone augments the antifungal effect of menadione—towards a novel anti‐Candida albicans combination therapy
201514 citationsauthor #9
Serum interleukin-6 levels in murine models of Candida albicans infection.
201412 citationsauthor #5
Killing rates exerted by caspofungin in 50 % serum and its correlation with in vivo efficacy in a neutropenic murine model against Candida krusei and Candida inconspicua.
201416 citationsauthor #7
A potential role of aminoglycoside resistance in endemic occurrence of Pseudomonas aeruginosa strains in lower airways of mechanically ventilated patients.
20147 citationsauthor #7
Killing Rates for Caspofungin Against Candida albicans After Brief and Continuous Caspofungin Exposure in the Presence and Absence of Serum
20148 citationsauthor #7
Examination of pharmacodynamics for caspofungin against Candida albicans
20140 citationsauthor #1
Studies on the possible aetiological role of different Candida species in pathogenesis of dentine caries by monitoring the calcium release from tooth particles.
20149 citationsauthor #2
Efficacy of single large doses of caspofungin in a neutropenic murine model against the "psilosis" group.
20143 citationsauthor #8
A practical example of the challenges of biota monitoring under the Water Framework Directive
201412 citationsauthor #2
Full method validation for the determination of hexachlorobenzene and hexachlorobutadiene in fish tissue by GC-IDMS.
201310 citationsauthor #1
Echinocandins: production and applications
2013101 citationsauthor #2
Effect of nikkomycin Z and 50% human serum on the killing activity of high-concentration caspofungin against Candida species using time-kill methodology
201221 citationsauthor #5
Effect of 50% human serum on the killing activity of micafungin against eight Candida species using time-kill methodology.
201212 citationsauthor #6
Comparison of In Vitro and Vivo Efficacy of Caspofungin Against Candida parapsilosis, C. orthopsilosis, C. metapsilosis and C. albicans
201221 citationsauthor #9
Comparison of the Kidney Fungal Burden in Experimental Disseminated Candidiasis by Species of the Candida parapsilosis Complex Treated with Fluconazole, Amphotericin B and Caspofungin in a Temporarily Neutropenic Murine Model
201212 citationsauthor #7
Fusion of the Fc part of human IgG1 to CD14 enhances its binding to gram-negative bacteria and mediates phagocytosis by Fc receptors of neutrophils.
20124 citationsauthor #4
Protein phosphatase CaPpz1 is involved in cation homeostasis, cell wall integrity and virulence of Candida albicans.
201237 citationsauthor #6
Protein phosphatase CaPpz 1 is involved in cation homeostasis , cell wall integrity and virulence of Candida albicans
201212 citationsauthor #6
The in vitro and in vivo antifungal susceptibility testing of Candida parapsilosis sensu stricto , Candida orthopsilosis and Candida metapsilosis isolates by Judit Szilágyi Supervisor :
20120 citationsauthor #1
Efficacy of a Single 6 mg/kg versus Two 3 mg/Kg Caspofungin Doses for Treatment of Disseminated Candidiasis Caused by Candida albicans in a Neutropenic Mouse Model
20114 citationsauthor #9
Conference report “The Future of Reference Materials - Science and Innovation”
20111 citationsauthor #2
Preparation of polyurethane elastomers (PUEs) in a high-throughput workflow
20116 citationsauthor #1
In vitro efficacy of amphotericin B, 5‐fluorocytosine, fluconazole, voriconazole and posaconazole against Candida dubliniensis isolates using time‐kill methodology
201010 citationsauthor #9
A synthetic and in silico study on the highly regioselective Diels-Alder reaction of the polyenic antifungal antibiotics natamycin and flavofungin
20104 citationsauthor #4
Kinetic study of the polymerization of aromatic polyurethane prepolymers by high‐throughput experimentation
201021 citationsauthor #1
Effect of asymmetry of concentration-response curves on the results obtained by the receptorial responsiveness method (RRM): an in silico study.
201010 citationsauthor #3
The polymorphism of protein phosphatase Z1 gene in Candida albicans
201016 citationsauthor #3

TIMELINE

2000 4 citations

2001 9 citations

2002 14 citations

2003 36 citations

2004 46 citations

2005 59 citations

2006 63 citations

2007 68 citations

2008 76 citations

2009 34 citations

2010 140 citations

2011 11 citations

2012 119 citations

2013 111 citations

2014 67 citations

2015 28 citations

2016 124 citations

2017 49 citations

2018 69 citations

2019 209 citations

2020 269 citations

2021 141 citations

2022 81 citations

2023 24 citations

2024 15 citations

2025 13 citations

2026 0 citations

L. Majoros

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT